CEACAM5 and neoplasm: The patient's tumor marker levels were elevated prior to NAC, with a carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA19–9) level of 9.8 ng/mL and 114.0 U/mL, respectively.